One recent study on HNSCC patients in Taiwan reported a 29% mutation rate of FAT1 and showed significant correlations of FAT1 mutations with lymph node status and worse disease-free survival (DFS) [10]. The gene discussed is FAT1; the disease is head and neck squamous cell carcinoma.